A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Pembrolizumab in Adult Participants With Resectable Stage 3 or 4 Melanoma

Conditions: Melanoma Interventions: Drug: pembrolizumab; Drug: fianlimab HD; Drug: cemiplimab; Drug: fianlimab LD; Drug: Placebo Sponsors: Regeneron Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials